rmis4d0s | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/rmis4d0s_hasAnnotation_C0017767> <https://research.tib.eu/covid-19/entity/rmis4d0s_hasAnnotation_C3698360>
?:creator	<https://research.tib.eu/covid-19/entity/Roberts%2C_Christine_C.%3B_Oh%2C_Myoung-don%3B_Kim%2C_Eu_Suk%3B_Jeong%2C_Moonsup%3B_Lee%2C_Hyojin%3B_Racine%2C_Trina%3B_Reuschel%2C_Emma%3B_Remigio%2C_Celine%3B_Kane%2C_Deborah%3B_Kudchodkar%2C_Sagar%3B_White%2C_Scott%3B_Park%2C_Young_K.%3B_Weiner%2C_David_B.%3B_Maslow%2C_Joel_N.>
?:journal	Molecular_Therapy
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/rmis4d0s_HAS_C0042210_TREATS_C3698360>
?:source	WHO
?:title	Phase I-IIA Study of GLS-5300 Vaccine for Mers-Cov: Preliminary Results Demonstrate B and T Cell Immune Response Elicited in Lower-Dose 2-and 3-Vaccination Intradermally Administered Regimens
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#613811
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/rmis4d0s>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/rmis4d0s>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all